Perspectives of key interest groups regarding supervised Consumption sites (SCS) and novel virtual harm reduction services / overdose response hotlines and applications: a qualitative Canadian study

Author:

Seo Boogyung,Rioux William,Teare Adrian,Rider Nathan,Jones Stephanie,Taplay Pamela,Ghosh S. Monty

Abstract

Abstract Background Supervised consumption sites (SCS) and overdose prevention sites (OPS) have been implemented across Canada to mitigate harms associated with illicit substance use. Despite their successes, they still contend with challenges that limit their accessibility and uptake. Overdose response hotlines and apps are novel virtual technologies reminiscent of informal “spotting” methods that may address some of the limitations. Here, we strove to qualitatively examine the factors that may encourage or deter utilization of these virtual services and SCS. Methods A total of 52 participants across Canada were recruited using convenience and snowball sampling methods. These included people with lived and living experience of substance use, family members of people with lived experience, healthcare providers, community harm reduction workers, and virtual harm reduction operators. Semi-structured telephone interviews were conducted and inductive thematic analysis was performed to identify the themes pertaining to SCS and virtual harm reduction. Results Participants viewed overdose response hotline and apps as an opportunity to consume substances without being hindered by logistical barriers (e.g., wait times), fear of law enforcement, invasion of privacy, and more. They also noted that these virtual services provided more flexibility for clients who opt for routes of consumption that are not supported by SCS, such as smoking. Overall, SCS was perceived to be better than virtual services at facilitating social connection, providing additional resources/referrals, as well as prompt response to overdose. Conclusion In sum, participants viewed SCS and virtual services as filling different needs and gaps. This study adds to a growing body of literature which informs how virtual harm reduction services can serve as useful adjunct to more standard harm reduction methods.

Funder

Health Canada’s Substance Use and Addictions Program (SUAP) Grant

Canadian Institutes of Health Research (CIHR) Grant

Publisher

Springer Science and Business Media LLC

Reference57 articles.

1. Health Canada. Health Canada announces nearly $40 million in funding to help support people who use substances across Canada [Internet]. 2022 [cited 2023 Aug 24]. https://www.canada.ca/en/health-canada/news/2022/07/health-canada-announces-suap-funding-to-support-people-who-use-substances-across-canada.html.

2. Health Canada. Government of Canada announces more than $21 million to support community-based organization who are helping address harms related to substance use [Internet]. 2023 [cited 2024 Jun 20]. https://www.canada.ca/en/health-canada/news/2023/10/government-of-canada-announces-more-than-21-million-to-support-community-based-organization-who-are-helping-address-harms-related-to-substance-use.html.

3. Health Canada. Opioid- and Stimulant-related Harms — Canada.ca [Internet]. 2023 [cited 2023 Jul 19]. https://health-infobase.canada.ca/substance-related-harms/opioids-stimulants/.

4. Health Canada. aem. 2020 [cited 2023 Aug 29]. Canadian supervised consumption sites statistics — Canada.ca. https://health-infobase.canada.ca/datalab/supervised-consumption-sites-blog.html.

5. Collins AB, Boyd J, Hayashi K, Cooper HLF, Goldenberg S, McNeil R. Women’s utilization of housing-based overdose prevention sites in Vancouver, Canada: an ethnographic study. Int J Drug Policy. 2020;76:102641.

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号  京ICP备18003416号-3